22-35745960-G-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_001349999.2(RBFOX2):āc.1262C>Gā(p.Ala421Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000304 in 1,613,942 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.0000066 ( 0 hom., cov: 32)
Exomes š: 0.000033 ( 0 hom. )
Consequence
RBFOX2
NM_001349999.2 missense
NM_001349999.2 missense
Scores
3
4
10
Clinical Significance
Conservation
PhyloP100: 7.66
Genes affected
RBFOX2 (HGNC:9906): (RNA binding fox-1 homolog 2) This gene is one of several human genes similar to the C. elegans gene Fox-1. This gene encodes an RNA binding protein that is thought to be a key regulator of alternative exon splicing in the nervous system and other cell types. The protein binds to a conserved UGCAUG element found downstream of many alternatively spliced exons and promotes inclusion of the alternative exon in mature transcripts. The protein also interacts with the estrogen receptor 1 transcription factor and regulates estrogen receptor 1 transcriptional activity. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BS2
High AC in GnomAdExome4 at 48 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RBFOX2 | NM_001349999.2 | c.1262C>G | p.Ala421Gly | missense_variant | 13/14 | ENST00000695854.1 | NP_001336928.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RBFOX2 | ENST00000695854.1 | c.1262C>G | p.Ala421Gly | missense_variant | 13/14 | NM_001349999.2 | ENSP00000512219.1 | |||
RBFOX2 | ENST00000438146.7 | c.1274C>G | p.Ala425Gly | missense_variant | 13/14 | 1 | ENSP00000413035.2 | |||
RBFOX2 | ENST00000449924.6 | c.1061C>G | p.Ala354Gly | missense_variant | 12/13 | 1 | ENSP00000391670.2 | |||
RBFOX2 | ENST00000414461.6 | c.1021C>G | p.Pro341Ala | missense_variant | 11/12 | 1 | ENSP00000407855.2 | |||
RBFOX2 | ENST00000695805.1 | n.*555C>G | non_coding_transcript_exon_variant | 12/13 | ENSP00000512185.1 | |||||
RBFOX2 | ENST00000695807.1 | n.*4245C>G | non_coding_transcript_exon_variant | 14/15 | ENSP00000512187.1 | |||||
RBFOX2 | ENST00000695805.1 | n.*555C>G | 3_prime_UTR_variant | 12/13 | ENSP00000512185.1 | |||||
RBFOX2 | ENST00000695807.1 | n.*4245C>G | 3_prime_UTR_variant | 14/15 | ENSP00000512187.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152168Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
1
AN:
152168
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 251368Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135862
GnomAD3 exomes
AF:
AC:
4
AN:
251368
Hom.:
AF XY:
AC XY:
2
AN XY:
135862
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000328 AC: 48AN: 1461774Hom.: 0 Cov.: 30 AF XY: 0.0000303 AC XY: 22AN XY: 727190
GnomAD4 exome
AF:
AC:
48
AN:
1461774
Hom.:
Cov.:
30
AF XY:
AC XY:
22
AN XY:
727190
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152168Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74338
GnomAD4 genome
AF:
AC:
1
AN:
152168
Hom.:
Cov.:
32
AF XY:
AC XY:
0
AN XY:
74338
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
1
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 19, 2023 | This sequence change replaces alanine, which is neutral and non-polar, with glycine, which is neutral and non-polar, at codon 425 of the RBFOX2 protein (p.Ala425Gly). This variant is present in population databases (rs773996802, gnomAD 0.007%). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. This variant has not been reported in the literature in individuals affected with RBFOX2-related conditions. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
.;.;T;.;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Pathogenic
D;D;D;D;D
M_CAP
Benign
D
MetaRNN
Uncertain
T;T;T;T;T
MetaSVM
Benign
T
PrimateAI
Pathogenic
T
PROVEAN
Benign
N;N;N;N;N
REVEL
Benign
Sift
Benign
T;D;D;D;T
Sift4G
Benign
T;T;T;T;T
Polyphen
P;P;P;P;P
Vest4
MutPred
0.39
.;.;Gain of catalytic residue at A331 (P = 0.0379);.;.;
MVP
MPC
2.1
ClinPred
D
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at